The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer | Citedby Results | Urologia Internationalis | Karger Publishers

Skip to Main Content

Skip Nav Destination

The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer

Urol Int (2011) 86 (1): 53–59.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer

Nirmala Ghimirey
Chase Steele
Brian J. Czerniecki
Gary K. Koski
Loral E. Showalter
Marie McIlroy

International Journal of Breast Cancer (2021) 2021: 1.

PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay

Alessia Cimadamore
Francesco Massari
Matteo Santoni
Antonio Lopez-Beltran
Liang Cheng
Marina Scarpelli
Rodolfo Montironi
Holger Moch

Current Drug Targets (2020) 21 (16): 1664.

Epidermal Growth Factor Receptor Inhibitors and Other Tyrosine Kinase Inhibitors for Solid Tumors

Isabel Ruiz-Camps
Juan Aguilar-Company

Infectious Disease Clinics of North America (2020) 34 (2): 257.

The Identification of Immunological Biomarkers in Kidney Cancers

Antonio Lopez-Beltran
Vanessa Henriques
Alessia Cimadamore
Matteo Santoni
Liang Cheng
Thomas Gevaert
Ana Blanca
Francesco Massari
Marina Scarpelli
Rodolfo Montironi

Frontiers in Oncology (2018) 8

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)

J. Aguilar-Company
M. Fernández-Ruiz
R. García-Campelo
A.C. Garrido-Castro
I. Ruiz-Camps

Clinical Microbiology and Infection (2018) 24: S41.

Sunitinib does not impair natural killer cell function in patients with renal cell carcinoma

Jennifer Moeckel
Nina Staiger
Andreas Mackensen
Norbert Meidenbauer
Evelyn Ullrich

Oncology Letters (2017) 14 (1): 1089.

Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinib

Gaёlle Noé
Audrey Bellesoeur
Audrey Thomas-Schoemann
Savithri Rangarajan
Faris Naji
Alicja Puszkiel
Olivier Huillard
Nathaniel Saidu
Lisa Golmard
Jerome Alexandre
Francois Goldwasser
Benoit Blanchet
Michel Vidal

Oncotarget (2016) 7 (41): 67507.

Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors

Mark Reinwald
Tobias Boch
Wolf-Karsten Hofmann
Dieter Buchheidt

Biomarker Insights (2015) 10s3: BMI.S22430.

Combination of sunitinib with anti‐tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

Ritika Jaini
Patricia Rayman
Peter A. Cohen
James H. Finke
Vincent K. Tuohy

International Journal of Cancer (2014) 134 (7): 1695.

Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR‐TKIs and mTOR inhibitor

Matteo Santoni
Rossana Berardi
Consuelo Amantini
Luciano Burattini
Daniele Santini
Giorgio Santoni
Stefano Cascinu

International Journal of Cancer (2014) 134 (12): 2772.

Modulation of Immunity by Antiangiogenic Molecules in Cancer

Magali Terme
Orianne Colussi
Elie Marcheteau
Corinne Tanchot
Eric Tartour
Julien Taieb

Clinical and Developmental Immunology (2012) 2012: 1.